Catabasis Pharma (CATB) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts CATB Hot Sheet
Join SI Premium – FREE
Catabasis Pharma (NASDAQ: CATB) reported Q3 EPS of ($0.55), $0.09 better than the analyst estimate of ($0.64).
For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
- Bragg Gaming Group Inc. (BRAG) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
